January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
November 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE To determine the success of any juvenile-onset myopia intervention, it is...
September 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Red light, a short wavelength visible light of 600-700 nm, has...
June 28, 2023 BERLIN, Germany — Dopavision’s MyopiaX-1 clinical trial centers are now all active, screening and enrolling participants across Germany, Spain,...
January 16, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Less time spent outdoors is a primary risk factor for myopia...
July 1, 2021 By Erin Lam, BVisSci, MOptom, Research Optometrist, Brien Holden Vision Institute The rising prevalence of myopia and high myopia...